Optimising Antiresorptive Therapies in Postmenopausal Women: Why Do We Need to Give Due Consideration to the Degree of Suppression?

Author： Karsdal Morten A.   Qvist Per  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.15, 2006-01, pp. : 1909-1918

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Why Do We Need a New Journal in Paediatric Pharmacology?

By Grave G.D.  

Pediatric Drugs, Vol. 1, Iss. 1, 1999-01 ,pp. : 3-5

Adis International

Access to resources Recommend Favorite

Why Do We Believe that Breast Cancer in the Elderly is the Same as Breast Cancer in Young Women?

By Hughes Kevin S.  

Drugs & Aging, Vol. 25, Iss. 1, 2008-01 ,pp. : 47-48

Adis International

Access to resources Recommend Favorite

Antiplatelet Drugs - Do We Need New Options?: With a Reappraisal of Direct Thromboxane Inhibitors

By Coccheri Sergio  

Drugs, Vol. 70, Iss. 7, 2010-05 ,pp. : 887-908

Adis International

Access to resources Recommend Favorite

Do We Need Drug Therapy to Manage Mild Hypertension in the Elderly?

By Fagard R.H.  

Drugs & Aging, Vol. 21, Iss. 1, 2004-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Optimal Antagonism of the Renin-Angiotensin-Aldosterone System: Do We Need Dual or Triple Therapy?

By Werner Christian   Pöss Janine   Böhm Michael  

Drugs, Vol. 70, Iss. 10, 2010-07 ,pp. : 1215-1230

Adis International

Access to resources Recommend Favorite